1-2 of 2
Dennis D. Weisenberger
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Gene Expression Distinguishes Burkitt Lymphoma from Other Aggressive Lymphomas and Identifies Patients Who Are Highly Curable with Intensive Chemotherapeutic Regimens.

Sandeep S. Dave, K. Fu, G. Wright, Lloyd Lam, T. C. Greiner, Dennis D. Weisenberger, P. M. Kluin, E. Boerma, A. Rosenwald, G. Ott, H. K. Muller-Hermelink, R. D. Gascoyne, J. Delabie, L. M. Rimsza, R. M. Braziel, T. M. Grogan, E. Campo, E. S. Jaffe, J. Vose, J. O. Armitage, J. M. Connors, E. B. Smeland, S. Kvaloy, H. Holte, T. P. Miller, R. I. Fisher, E. Montserrat, W. H. Wilson, M. Bahl, H. Zhao, L. Yang, J. Powell, R. Simon, W. C. Chan, L. M. Staudt, Leukemia Lymphoma Molecular Profiling Project
Journal: Blood
Blood (2005) 106 (11): 415.
https://doi.org/10.1182/blood.V106.11.415.415
Published: 2005
Journal Articles

Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project

Clinical Trials & Observations
Lisa M. Rimsza, Robin A. Roberts, Thomas P. Miller, Joseph M. Unger, Michael LeBlanc, Rita M. Braziel, Dennis D. Weisenberger, Wing C. Chan, H. Konrad Muller-Hermelink, Elaine S. Jaffe, Randy D. Gascoyne, Elias Campo, Deborah A. Fuchs, Catherine M. Spier, Richard I. Fisher, Jan Delabie, Andreas Rosenwald, Louis M. Staudt, Thomas M. Grogan
Journal: Blood
Blood (2004) 103 (11): 4251–4258.
https://doi.org/10.1182/blood-2003-07-2365
Published: 2004